Annexon Biosciences is a biotechnology company focused on developing therapies to treat autoimmune, neurodegenerative, and ophthalmic diseases. The company specializes in targeting the C1q protein, a key initiator in the classical complement pathway, to block damaging immune responses and halt the progression of complement-driven diseases. Their research and development efforts aim to deliver transformative treatments for conditions affecting the body, brain, and eye. Annexon recently announced positive results from a Phase 3 trial of their C1q-blocking antibody ANX005 for treating Guillain-BarrΓ© syndrome.
Neurodegeneration β’ Autoimmune β’ Ophthalmology
4 days ago
Lead Medical Affairs strategy and execution for congress activities at Annexon Biosciences, a biopharma company. Collaborate with cross-functional teams to enhance scientific presence at major events.
πΊπΈ United States β Remote
π California β Remote
π΅ $238k - $252k / year
π° $130M Post-IPO Equity on 2022-07
β° Full Time
π΄ Lead
π Director
November 8
Strategic partner developing scientific content for Annexon's Geographic Atrophy objectives.
πΊπΈ United States β Remote
π΅ $223k - $248.8k / year
π° $130M Post-IPO Equity on 2022-07
β° Full Time
π΄ Lead
π£οΈ Communications
November 3
Annexon seeks a Field Medical Director in neurology to engage thought leaders.
πΊπΈ United States β Remote
π΅ $197k - $260k / year
π° $130M Post-IPO Equity on 2022-07
β° Full Time
π Senior
π¨ββοΈ Medical Director
November 1
Field Medical Director at Annexon focuses on neurologic diseases and stakeholder engagement.
πΊπΈ United States β Remote
π΅ $197k - $260k / year
π° $130M Post-IPO Equity on 2022-07
β° Full Time
π Senior
π¨ββοΈ Medical Director
October 31
Field Medical Director engaging thought leaders in neurology at Annexon Biosciences.
πΊπΈ United States β Remote
π΅ $197k - $260k / year
π° $130M Post-IPO Equity on 2022-07
β° Full Time
π Senior
π¨ββοΈ Medical Director
October 31
Field Medical Director/Senior Director at Annexon focusing on neurology therapies.
πΊπΈ United States β Remote
π΅ $197k - $260k / year
π° $130M Post-IPO Equity on 2022-07
β° Full Time
π Senior
π¨ββοΈ Medical Director
October 31
VP of Advocacy & Professional Relations for neuroinflammatory disease awareness.
πΊπΈ United States β Remote
π΅ $311k - $346k / year
π° $130M Post-IPO Equity on 2022-07
β° Full Time
π΄ Lead
π Vice President
October 31
Field Medical Director at Annexon Biosciences engaging key stakeholders in ophthalmology.
πΊπΈ United States β Remote
π΅ $197k - $260k / year
π° $130M Post-IPO Equity on 2022-07
β° Full Time
π Senior
π¨ββοΈ Medical Director
October 21
Vice President, Market Access leads strategy for Annexon's novel therapies.
πΊπΈ United States β Remote
π΅ $329k - $365k / year
π° $130M Post-IPO Equity on 2022-07
β° Full Time
π΄ Lead
π Vice President
October 20
Lead quality systems at a biopharmaceutical company enhancing compliance and processes.
πΊπΈ United States β Remote
π΅ $228k - $255k / year
π° $130M Post-IPO Equity on 2022-07
β° Full Time
π Senior
π Director